Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • Français
  • my CNW 
    • Login
    • Register
  • Client Login 
    • PR Newswire Amplify™
    • Next Gen Communications Cloud
    • Cision Communications Cloud®
  • Sign Up
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
Advanced Search
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Canadian Federal Government
      • Canadian Municipal Government
      • Canadian Provincial Government
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

  • Advanced Search
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • IR
  • All Products
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media
  • Worldwide Offices
  • Hamburger menu
  • Cision Canada
  • Send a Release
  • FR
    • Phone

    • 877-269-7890 from 8 AM - 10 PM ET

    • ALL CONTACT INFO
    • Contact Cision

      877-269-7890
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • IR
  • All Products
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR
  • Sign Up
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media Enquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Resources
  • Investor Relations
  • Journalists
  • Webcasts
  • my CNW
  • GDPR

Bio-K Plus, Quebec's #1 most pharmacist-recommended brand of probiotics in 2023,* expands its distribution in the Canadian pharmacy channel with Health Canada approved health claims. Français

Bio-K+, A Kerry Company (CNW Group/Bio-K+, A Kerry Company)

News provided by

Bio-K+, A Kerry Company

May 01, 2023, 08:37 ET

Share this article

Share toX

Share this article

Share toX

Bio-K+'s Pro line of probiotic supplements includes IBS Pro and Antibio Pro products for use in specific health conditions: for people with diarrhea-predominant irritable bowel syndrome or for diarrhea symptoms related to antibiotic therapy.

LAVAL, QC, May 1, 2023 /CNW/ - Bio-K Plus, A Kerry Company, pioneer in the probiotic sector and leader in the biotech industry, is pleased to announce the expansion of its Pro line of probiotic supplements in the pharmacy channel outside the province of Quebec. Furthermore, Bio-K+ has been awarded Quebec's #1 most pharmacist-recommended probiotic brand of 2023. *

Continue Reading
The Pro line is made up of two products, IBS Pro for irritable bowel syndrome and Antibio Pro when taking antibiotics. (CNW Group/Bio-K+, A Kerry Company)
The Pro line is made up of two products, IBS Pro for irritable bowel syndrome and Antibio Pro when taking antibiotics. (CNW Group/Bio-K+, A Kerry Company)

It all starts with one goal: to inspire individuals to understand that gut health is the foundation of good health. As a result, we recognize that we can only make an impactful difference in the lives of our consumers by providing them with science-backed products. Science and passion for consumer wellness are the driving forces behind all of our product innovations to enable individuals to take better care of their gut health.

Both products, now available nationally at Shoppers Drug Mart and Pharmaprix, offer consumers a clinically supported and natural OTC solution. Vegan and gluten-free, both products are generally recognized as safe with over 100,000 documented patient-cases in over 20 years of clinical research.1

"Having been a pioneer in probiotic supplements, Bio-K+ has always taken a leadership position in helping consumers improve their health and wellness," explains Fan Bonnett, Commercial VP at Bio-K Plus, "It is our duty to assist consumers who suffer from these uncomfortable conditions.

A new product must be formulated based on proven scientific evidence in order to deliver efficacious health benefits to consumers. Hence, our team has spent a significant amount of time developing these products to ensure maximum quality, safety, and efficacy. 

Our goal is to reach as many consumers in need as possible with our products. With the launch of the Pro line, we are setting the stage for further expansion into additional benefit areas and delighting a broader range of consumers."

The Pro line, listed in the Clinical Guide to Probiotic Products Available in Canada, features Bio-K Plus' three unique, patented and scientifically supported strains of bacteria. Bio-K+ IBS Pro, certified by the Canadian Digestive Health Foundation targets specific challenges faced by this large population with diarrhea-predominant irritable bowel syndrome (IBS-D). The prevalence of IBS in Canada is one of the highest in the world, estimated at 18%, with 40% of these cases associated with IBS-D.2 In a double-blind, randomized, placebo-controlled study, Bio-K+ IBS Pro was found to be effective in improving patient quality of life by 65%,3 reducing the number of days with abdominal pain by 50%,4 reducing the amount of liquid stools per week by 30%4 and improving stool consistency by 91%.3

Bio-K+ Antibio Pro helps reduce the risk of antibiotic-associated diarrhea (AAD), including C. difficile-associated diarrhea (CDAD). Antibiotics are commonly used to treat infections, but up to 35% of patients are at risk of developing AAD5 which can cause abdominal pain, gas, bloating, increased sensitivity to infections and can even lead to metabolic and immunological disorders.6 In a double-blind, randomized, placebo-controlled study,Bio-K+ Antibio Pro was found effective to help reduce the risk of AAD by 65%, abdominal pain by 68%, CDAD by 95% and the number of days with symptoms by 56%.7

About Bio-K Plus, A Kerry company

Founded in 1994, Bio-K Plus is part of Kerry Group, a world leader in taste and nutrition for the food, beverage and pharmaceutical markets, since October 2020. Based in Quebec, Canada, Bio-K+ is a probiotic industry leader & pioneer who specializes in the manufacturing of probiotics supported by 20+ years of scientific and clinical research. The company is strongly committed to developing new, innovative products that support the health of people around the world. For more information, visit biokplus.com.

For any inquiries about this press release please contact Viviane Lemire, Marketing Director.

References:

* Profession Santé 2023 Survey on OTC Counselling and Recommendations (re: pharmacists).
1. Bio-K+ Internal reporting. Updated May, 2021.
2. Lovell, R. M. et al. (2012). Clin Gastroenterol Hepatol, 10(7), 712–721.e4.
3. Preston, K. et al. (2018). Benef Microbes, 9(5), 697–706.
4. Ship, N. et al. (2019, October). Am J Gastroenterol, 114 (Supplement), S296–S297.
5. McFarland, L. V. (2008). Future microbiol, 3(5), 563–578.
6. Langdon, A. et al. (2016). Genome Med, 8(1), 39.
7. Gao, X. W. et al. (2010). Am J Gastroenterol, 105(7), 1636–1641.

SOURCE Bio-K+, A Kerry Company

Viviane Lemire, [email protected], Marketing Director

Modal title

Organization Profile

Bio-K+, A Kerry Company

    Also from this source

  • Bio-K+® Advances Research on Gut Health and Autism Spectrum Disorder with Promising Clinical Study Findings

Contact Cision

  • 866-245-2317
    from 8 AM - 10 PM ET
  • Become a Client
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • General Enquiries
  • Media

Products

  • Cision Communications Cloud®
  • Media Monitoring
  • Content Distribution
  • Multimedia Distribution
  • Measurement & Analytics
  • Investor Relations

About

  • About Cision Canada
  • About Cision
  • Media Partners
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Platform Login
  • Next Gen Communications Cloud
  • Cision Communications Cloud®
  • my CNW
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Platform
  • Next Gen Communications Cloud
  • Cision Communications Cloud
  • my CNW
877-269-7890
from 8 AM - 10 PM ET
  • Terms of Use
  • Information Security Policy
  • Site Map
  • Cookie Settings
  • Accessibility Statement
Copyright © 2025 CNW Group Ltd. All Rights Reserved. A Cision company.